<html>
<head>PUBMED IDs for EGP-2</head>
<body bgcolor='#C5F0F2'><h1>EGP-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7731047/'>Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions.</a> April 21  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9212242/'>Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.</a> July 3  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9836471/'>High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.</a> December 4  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10473805/'>An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.</a> September 4  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10646635/'>Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors.</a> January 26  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10677285/'>Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.</a> March 15  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11358833/'>The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.</a> May 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12202902/'>Comparison of the TCR zeta-chain with the FcR gamma-chain in chimeric TCR constructs for T cell activation and apoptosis.</a> August 31  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14671978/'>Real-time reverse transcription-polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions.</a> December 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14695757/'>A nonviral carrier for targeted gene delivery to tumor cells.</a> December 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15243630/'>Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.</a> July 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15696177/'>Evaluation of tumor-specific promoter activities in melanoma.</a> February 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16096650/'>The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.</a> August 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17137670/'>Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoter.</a> December 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17186549/'>Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatment.</a> December 23  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19515379/'>Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.</a> September 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19515372/'>Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention.</a> January 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/24391761/'>Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapy.</a> August 26  2014<br></body></html>
